Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2008
11/05/2008EP1646720B1 Antibodies against insulin-like growth factor i receptor and uses thereof
11/05/2008EP1526140B1 Potassium-dependent sodium-calcium exchanger
11/05/2008EP1465996B1 Raf/ras binding compounds
11/05/2008EP1363937B1 Immunomodulating agents from parasitic worms and method for isolation thereof
11/05/2008EP1141716B1 Method for the cellular high-throughput-detection of receptor ligand interactions
11/05/2008EP1127104B1 Method for the massive culture of cells producing recombinant human erythropoietin
11/05/2008EP0994724B1 Methods and compositions for impairing multiplication of hiv-1
11/05/2008CN101300350A Promoter for introducing gene into lymphocyte or blood cell and application thereof
11/05/2008CN101300347A Sequence capable of enhancing the expression of gene under moderately low temperature
11/05/2008CN101300343A Multipotent stem cells derived from human adipose tissue and cellular therapeutic agents comprising the same
11/05/2008CN101300342A Methods for adapting mammalian cells
11/05/2008CN101300340A Cell culture apparatus, cell culture method, cell culture program and cell culture system
11/05/2008CN101300339A Shaker for cell culture and shaken culture system in cell culture method
11/05/2008CN101299046A Method for detecting erythromycin series compounds and special-purpose enzyme-linked immunologic reagent kit thereof
11/05/2008CN101298616A Promoter for expressing phosphor deficiency speciality induction in root and use thereof
11/05/2008CN101298611A Active fragment of chlamydia proteasome sample active factor and expression method thereof
11/05/2008CN101298607A Production method of recombinant human follicle-stimulating growth hormone
11/05/2008CN101298606A Preparation, storage and use of umbilical cord and placenta mesenchymal stem cell for clinical therapy
11/05/2008CN101298605A Hepatitis C virus in vitro replication model, construction method and use thereof
11/05/2008CN101298592A Cell three-dimensional mechanical loading unit
11/05/2008CN101298481A Inhibitors of complement activation
11/05/2008CN101298479A Antibodies for inhibiting blood coagulation and methods of use thereof
11/05/2008CN101298478A Method for detecting and purifying CD8+T lymphocyte populations, specific of peptides present in context of hla
11/05/2008CN101298285A Airtight transporting blending metering system and method for powder culture medium
11/05/2008CN101297637A Plant tissue culture method for thinly-skinned walnut
11/05/2008CN101297635A Method for breeding spore of Dryopteris varia
11/05/2008CN101297634A Chinese jujube high-efficiency cross breeding method based on application of male sterility and embryo cultivation
11/05/2008CN100430727C Assaying protein fragments in body fluids
11/05/2008CN100430482C Novel expression vectors and uses thereof
11/05/2008CN100430478C CASB618 polynucleotides and polypeptides and their use
11/05/2008CN100430477C Hamster EF-1 'alpha' transcriptional regulatory DNA
11/05/2008CN100430473C Hybrid tumor cell strain and its produced human alpha-galactosidase A resisting monoclonal antibody
11/05/2008CN100430472C Canine semen dilution liquid
11/05/2008CN100430420C Human CDR-grafted antibodies and antibody fragments thereof
11/05/2008CN100430419C Anti-CD40 monoclonal antibody
11/05/2008CN100430418C Method of preparing monoclonal antibody, monoclonal antibody, pharmaceutical composition and diagnostic reagent
11/05/2008CN100430412C Nucleic acid molecule RTN4BSR6 and application for preparation of anti-cancer drugs
11/05/2008CN100429972C Tissue culture propagation process of late spring michelia
11/04/2008US7446244 Soybean cultivar 6408448
11/04/2008US7446241 Using vector transformation to generate transgenic plants with enhanced resistance to drought and high environments
11/04/2008US7446239 Comprises spinocerebellar ataxias (SCAs) genes; neurodegenerative disorders; homologous recombination; genes
11/04/2008US7446191 Expression vector comprising nucleotide sequences coding t-cell receptor for use in generation of monoclonal antibody for treatement of cell proliferative disorders
11/04/2008US7446185 Vector comprising nucleotide sequences coding oncogenic protein for use in identication of modulators for treatment and prevention of cell proliferative and metabolic disorders
11/04/2008US7446183 Fusion protein comprising growth hormone and growth hormone receptor
11/04/2008US7446180 Conformationally abnormal forms of tau proteins and specific antibodies thereto
11/04/2008US7446179 CD19-specific chimeric T cell receptor
11/04/2008US7446171 Encoded by nucleic acid of given sequence; hybridizes to complement of nucleic acid; use as molecular weight markers,
11/04/2008US7445932 Development of a highly efficient in vitro system of micropropagation of solanum viarum
11/04/2008US7445931 Compositions and methods for enrichment of neural stem cells using ceramide analogs
11/04/2008US7445930 Method for the production and purification of adenoviral vectors
11/04/2008US7445922 Enhance effects of an endoglucanase enzyme on fabric treatment such as reduction of fuzzing, improvement in feel and appearance, color clarification, partial color change, and softening of cellulose-containing fabrics
11/04/2008US7445920 Member of the lysyl oxidase gene family
11/04/2008US7445913 Recombinant cell comprising expression vector; transcription; new cytokine that stimulates hematopoietic cells
11/04/2008US7445905 Contacting cells with receptor and determining formation of complexes; modulating gene expression in acinar cells of pancreatitis associated protein
11/04/2008US7445890 Screening for compound that inhibits uncoupling protein (Ucp) activity; measuring expression level of reporter molecule (luciferase) in transformant; drugs for obesity, diabetes, depression
11/04/2008US7445798 Transgenic cells comprising nucleotide sequences coding fetal liver kinase-1 receptors; for use self-renewal of totipotent hematopoietic stem cell and to stimulate the development of all cells of the hematopoietic system both in vitro and in vivo
11/04/2008US7445793 Support for tissue regeneration and process for producing the same
11/04/2008US7445780 Antagonistic anti-CD40 antibodies
11/04/2008US7445776 Mincing tissue, culturing with growth factors, bone morphogenetic protein or vitamin D; propagating in alginate, agarose and collagen to form 3-dimensional structure
11/04/2008CA2486330C Stress-responsive root-specific genes
11/04/2008CA2192849C Dna molecules which code for a plastid 2-oxoglutarate/malate translocator
11/04/2008CA2182890C Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells
11/01/2008CA2627079A1 Expressing glk in plants
10/2008
10/30/2008WO2008131375A1 Methods of protein production using anti-senescence compounds
10/30/2008WO2008131374A1 Use of low temperature and/or low ph in cell culture
10/30/2008WO2008131004A1 Telencephalic glial-restricted cell populations and related compositions and methods
10/30/2008WO2008130985A2 Plants with multiple transgenes on a chromosome
10/30/2008WO2008130100A1 Semi-mature dentritic cell
10/30/2008WO2008130053A1 Fused protein comprising protein g with avidin
10/30/2008WO2008130034A1 Polyamino acid synthetase and gene encoding the same
10/30/2008WO2008130025A1 Hepatocyte culture container and hepatocyte culture method
10/30/2008WO2008129997A1 Composition of solubilized amnion and use thereof
10/30/2008WO2008129971A1 Improved persistently infective sendai virus vector
10/30/2008WO2008129699A1 Chimeric fusicoccane synthase and gene of the same
10/30/2008WO2008129563A2 Human mesenchymal stem cells and preparation thereof
10/30/2008WO2008129554A1 Stem cell-derived retinal pigment epithelial cells
10/30/2008WO2008129422A1 Demannosylated recombinant factor viii for the treatment of patients with haemophilia a
10/30/2008WO2008128717A1 Improved three-dimensional biocompatible skeleton structure containing nanoparticles
10/30/2008WO2008128293A1 Manipulation of plant senescence using modified promoters
10/30/2008WO2008112297A3 Methods of treating cancer by interfering with igf-i receptor signaling
10/30/2008WO2008109659A3 Complexes of hyaluronans, other matrix components, hormones and growth factors for maintenance, expansion and/or differentiation of cells
10/30/2008WO2008109533A3 Human antibodies that bind multiple irta family proteins, and uses thereof
10/30/2008WO2008104062A3 Selective release of pro-apoptotic bcl-2 family members and their contribution to the bystander effect
10/30/2008WO2008103471A3 Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease
10/30/2008WO2008101350A8 Altering carotenoid profiles in plants
10/30/2008WO2008100498A3 Treatment of inflammatory diseases using placental stem cells
10/30/2008WO2008099006A3 Mitogen independence identifies a highly malignant population of tumor stem cells
10/30/2008WO2008095027A3 Adenoviral vector comprising herpes simplex virus type 1 thymidine kinase and a transgene for increasing the expression of the transgene
10/30/2008WO2008094597A3 Early mesoderm cells, a stable population of mesendoderm cells that has utility for generation of endoderm and mesoderm lineages and multipotent migratory cells (mmc)
10/30/2008WO2008091830A3 Maintenance and propagation of mesenchymal stem cells
10/30/2008WO2008089448A3 Methods and compositions for promoting survival & proliferation of endothelial cells & stimulating angiogenesis
10/30/2008WO2008075206A3 Cell-matrix microspheres, methods for preparation and applications
10/30/2008WO2008071974A3 Use of pi3k m-tor and akt inhibitors to induce f0xp3 expression and generate regulatory t cells
10/30/2008WO2008068498A3 Regulation of plant metabolism
10/30/2008WO2008067032A3 Transgenic mice expressing a real-time reporter for cellular camp in a tissue-selective and inducible manner
10/30/2008WO2008057162A3 Native (telopeptide) placental collagen compositions
10/30/2008WO2008054724A3 Monoclonal antibodies against osteopontin
10/30/2008WO2008036953A3 In vivo transformation of pancreatic acinar cells into insulin-producing cells
10/30/2008WO2008036374A3 Allogeneic stem cell transplants in non-conditioned recipients
10/30/2008WO2008031056A3 Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease